Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/s-0034-1393971 http://scihub22266oqcxt.onion/10.1055/s-0034-1393971 C4232427!4232427!25435660     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25435660&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 500 Internal Server Error in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Intervent+Radiol 2014 ; 31 (4): 345-52 Nephropedia Template TP {{tp|p=25435660|t=2014. Treating Femoropopliteal Disease: Established and Emerging Technologies |pdf=|usr=}}{{25435660}} gab.com Text Treating Femoropopliteal Disease: Established and Emerging Technologies JO: Semin Intervent Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25435660 #FOAvip The femoropopliteal artery is the most common site of disease in patients with peripheral arterial disease and presents some of the greatest challenges for interventional radiology. Many patients can be managed with medical treatment combined with supervised exercise alone. However, a significant proportion, especially those suffering from severe intermittent claudication or critical limb ischemia, will require some form of endovascular or surgical revascularization procedure. During the past few years an endovascular-first approach has gained support from all vascular specialties. Today, even complex lesions can be treated successfully with an endovascular approach. Unfortunately, the unique bio-mechanical properties of this vascular segment have limited long-term patency rates and clinical value of the endovascular options. In this review, the authors discuss the methods and techniques for treatment of femoropopliteal lesions and review the current evidence for commercially available devices on patency outcomes following successful recanalization. Twit Text FOAVip Treating Femoropopliteal Disease: Established and Emerging Technologies ????Semin Intervent Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25435660 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25435660 #FOAvip English Wikipedia <ref>{{Cite pmid|25435660}}</ref> Treating Femoropopliteal Disease: Established and Emerging Technologies #MMPMID25435660 Diamantopoulos A; Katsanos K Semin Intervent Radiol 2014[Dec]; 31 (4): 345-52 PMID25435660show ga The femoropopliteal artery is the most common site of disease in patients with peripheral arterial disease and presents some of the greatest challenges for interventional radiology. Many patients can be managed with medical treatment combined with supervised exercise alone. However, a significant proportion, especially those suffering from severe intermittent claudication or critical limb ischemia, will require some form of endovascular or surgical revascularization procedure. During the past few years an endovascular-first approach has gained support from all vascular specialties. Today, even complex lesions can be treated successfully with an endovascular approach. Unfortunately, the unique bio-mechanical properties of this vascular segment have limited long-term patency rates and clinical value of the endovascular options. In this review, the authors discuss the methods and techniques for treatment of femoropopliteal lesions and review the current evidence for commercially available devices on patency outcomes following successful recanalization. äTreating Femoropopliteal Disease: Established and Emerging Technologie(epmc).pdf DeepDyve Pubget Overpricing